HMOX1 and breast carcinoma: Survival analysis in the PrognoScan database (www.prognoscan.org/, accessed on 10 March 2023) provided strong evidence that high HO-1 mRNA expression predicts significantly worse prognosis in lung cancer, breast cancer, blood cancer, brain cancer, colorectal cancer, and ovarian cancer (Figure 2).